6-苯基-1,2,4,5-四嗪-3-胺 | 14418-30-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四嗪
• 中文名称: 6-苯基-1,2,4,5-四嗪-3-胺
• 英文名称: 6-amino-3-phenyl-1,2,4,5-tetrazine
• 英文别名: 6-phenyl-[1,2,4,5]tetrazin-3-ylamine；6-Phenyl-[1,2,4,5]tetrazin-3-ylamin；6-amino-3-phenyl-1,2,4,5-tetrazin；6-phenyl-1,2,4,5-tetrazin-3-amine；3-Amino-6-phenyl-1,2,4,5-tetrazin；3-Amino-6-phenyl-s-tetrazin
• CAS: 14418-30-5
• 化学式: C₈H₇N₅
• 分子量: 173.177
• InChiKey: SRKIOURBMJJDMZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  77.6
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  6-苯基-1,2,4,5-四嗪-3-胺 在 溴 、 一水合肼 作用下， 生成 3-bromo-6-phenyl-1,2,4,5-tetrazine
  参考文献：
  名称：

  Occurrence of the SN(ANRORC) mechanism in the hydrazination of 1,2,4,5-tetrazines

  摘要：

  DOI：

  10.1021/jo00338a009
• 作为产物：
  描述：

  3-bromo-6-phenyl-1,2,4,5-tetrazine 在 氨 作用下， 生成 6-苯基-1,2,4,5-四嗪-3-胺
  参考文献：
  名称：

  IV. Some 3,6-Unsymmetrically Disubstituted 1,2,4,5-Tetrazines^1a,b,c

  摘要：

  DOI：

  10.1021/ja01545a060

文献信息

• 7-AZASPIRO[3.5]NONANE-7-CARBOXAMIDE COMPOUNDS
  申请人：Long Scott A.

  公开号：US20100113465A1

  公开（公告）日：2010-05-06

  Provided herein are 7-azaspiro[3.5]nonane-7-carboxamide compounds and the pharmaceutically acceptable salts of such compounds useful in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity, conditions including including acute pain, chronic pain, neuropathic pain, nociceptive pain, inflammatory pain, cancer and cancer pain, fibromyalgia, rheumatoid arthritis, inflammatory bowel disease, lupus, diabetes, allergic asthma, vascular inflammation, urinary incontinence, overactive bladder, emesis, cognitive disorders, anxiety, depression, sleeping disorders, eating disorders, movement disorders, glaucoma, psoriasis, multiple sclerosis, cerebrovascular disorders, brain injury, gastrointestinal disorders, hypertension, or cardiovascular disease.

  本文提供了7-azaspiro[3.5]nonane-7-carboxamide化合物及其药用可接受盐，用于治疗与脂肪酸酰胺水解酶（FAAH）活性相关的疾病或症状，包括急性疼痛、慢性疼痛、神经病性疼痛、伤害性疼痛、炎症性疼痛、癌症及癌症疼痛、纤维肌痛、类风湿性关节炎、炎症性肠病、狼疮、糖尿病、过敏性哮喘、血管炎症、尿失禁、膀胱过度活跃、呕吐、认知障碍、焦虑、抑郁、睡眠障碍、进食障碍、运动障碍、青光眼、牛皮癣、多发性硬化、脑血管疾病、脑损伤、胃肠道疾病、高血压或心血管疾病。
• [EN] NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME<br/>[FR] NOUVEAUX COMPOSÉS ORGANIQUES ÉLECTROLUMINESCENTS ET DISPOSITIF ORGANIQUE ÉLECTROLUMINESCENT ASSOCIÉ
  申请人：ROHM & HAAS ELECT MAT

  公开号：WO2011136484A1

  公开（公告）日：2011-11-03

  Provided are novel organic electroluminescent compounds and an organic electroluminescent device using the same. Since the organic electroluminescent compound exhibits high luminous efficiency in blue color and excellent life property, it may be used to manufacture OLEDs having very superior operation life.

  提供了新颖的有机电致发光化合物以及使用这些化合物的有机电致发光装置。由于这种有机电致发光化合物在蓝色方面表现出高发光效率和优秀的寿命特性，因此可以用于制造具有非常优越运行寿命的OLED。
• [EN] 7-AZASPIRO [3.5] NONANE-7-CARBOXAMIDE COMPOUNDS AS MODULATORS OF FATTY ACID AMIDE HYDROLASE<br/>[FR] COMPOSÉS 7-AZASPIRO[3.5]NONANE-7-CARBOXAMIDE COMME MODULATEURS DE L'HYDROLASE D'AMIDES D'ACIDES GRAS
  申请人：PFIZER

  公开号：WO2010049841A1

  公开（公告）日：2010-05-06

  Provided herein are 7-azaspiro[3.5]nonane-7-carboxamide compounds and the pharmaceutically acceptable salts of such compounds useful in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity, conditions including including acute pain, chronic pain, neuropathic pain, nociceptive pain, inflammatory pain, cancer and cancer pain, fibromyalgia, rheumatoid arthritis, inflammatory bowel disease, lupus, diabetes, allergic asthma, vascular inflammation, urinary incontinence, overactive bladder, emesis, cognitive disorders, anxiety, depression, sleeping disorders, eating disorders, movement disorders, glaucoma, psoriasis, multiple sclerosis, cerebrovascular disorders, brain injury, gastrointestinal disorders, hypertension, or cardiovascular disease.

  本文提供了7-azaspiro[3.5]nonane-7-carboxamide化合物及其药学上可接受的盐，用于治疗与脂肪酸酰胺水解酶（FAAH）活性相关的疾病或症状，包括急性疼痛、慢性疼痛、神经病理性疼痛、伤害性疼痛、炎症性疼痛、癌症和癌痛、纤维肌痛、类风湿性关节炎、炎症性肠病、狼疮、糖尿病、过敏性哮喘、血管炎症、尿失禁、膀胱过度活动、呕吐、认知障碍、焦虑、抑郁、睡眠障碍、进食障碍、运动障碍、青光眼、银屑病、多发性硬化症、脑血管疾病、脑损伤、胃肠道疾病、高血压或心血管疾病。
• Counotte-Potman, Anda; Plas, Henk C. van der, Journal of Heterocyclic Chemistry, 1981, vol. 18, p. 123 - 127
  作者：Counotte-Potman, Anda、Plas, Henk C. van der

  DOI：——

  日期：——
• COUNOTTE-POTMAN A.; PLAS H. C. VAN DER, J. HETEROCYCL. CHEM., 1981, 18, NO 1, 123-127
  作者：COUNOTTE-POTMAN A.、 PLAS H. C. VAN DER

  DOI：——

  日期：——